BOSTON HEART DIAGNOSTICS CORPORATION
FRAMINGHAM, MA

BOSTON HEART DIAGNOSTICS CORPORATION is an Active company incorporated on June 5, 2009 with the registered number F09000002262. This Foreign for Profit company is located at 175 Crossing Blvd., FRAMINGHAM, MA, 01702, US and has been running for sixteen years. There are currently three active principals.

KEY FACTS ABOUT BOSTON HEART DIAGNOSTICS CORPORATION

  1. US Businesses
  2. Companies in Florida
  3. Leon County Companies
Company name
BOSTON HEART DIAGNOSTICS CORPORATION
Status
Active
Filed Number
F09000002262
FEI Number
208833340
Date of Incorporation
June 5, 2009
Age - 16 years
Home State
DE
Company Type
Foreign for Profit

BOSTON HEART DIAGNOSTICS CORPORATION NEAR ME

Principal Address
175 Crossing Blvd.,
FRAMINGHAM,
MA,
01702,
US

See Also

BOSTON HAIR AND BODY WORKS LLC BOSTON HANDYMAN & INSTALLATION LLC BOSTON HOLDING COMPANY LLC BOSTON HOLDING GROUP LLC BOSTON HOLDING MANAGEMENT COMPANY LLC

Officers and Directors

The BOSTON HEART DIAGNOSTICS CORPORATION managed by the three persons from FRAMINGHAM, Des Moines, Lenexa on following positions: President, Trea, Director

Scott Madel

Position
President Active
From
FRAMINGHAM, MA, MA
Scott Madel Related Companies

Dan Dickinson

Position
Trea Active
From
Des Moines, IA, IA
Dan Dickinson Related Companies
  1. DNA DIAGNOSTICS CENTER, INC.
  2. EUROFINS MICROBIOLOGY LABORATORIES, INC.
  3. EUROFINS LANCASTER LABORATORIES, INC
  4. EUROFINS FOOD CHEMISTRY TESTING DES MOINES, INC.
  5. EUROFINS DONOR & PRODUCT TESTING, INC.
  6. EUROFINS LANCASTER LABORATORIES ENVIRONMENT TESTING, LLC

Matthew G Urbanek

Position
Director Active
From
Lenexa, KS, KS
Matthew G Urbanek Related Companies
  1. EUROFINS DONOR & PRODUCT TESTING, INC.
  2. CLINICAL ENTERPRISE, INC.
  3. EUROFINS CLINICAL DIAGNOSTIC US NDSC, INC.
  4. EUROFINS DONOR & PRODUCT TESTING, LLC



Registered Agent is COGENCY GLOBAL INC.

Address
115 NORTH CALHOUN STREET, SUITE 4, TALLAHASSEE, FL, 32301

Events

April 19, 2011
NAME CHANGE AMENDMENT

Annual Reports

2024
April 10, 2024
2023
April 26, 2023